Skip to main content
KPTI filings

Corporate insider profile

Richard A. Paulson Filing Activity

Latest reported as President and CEO of Karyopharm Therapeutics Inc. (KPTI).

Purchase filings
0
Reported companies
1
Net open-market value
-$20,928.50
Latest transaction
May 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 14, 2026Karyopharm Therapeutics Inc. (KPTI)President and CEOSale2,203$9.50$20,929